mortality/aging
• when infected with a LD50 dose of wild-type MCMV, about 90% of mice survive compared to 50-60% of wild-type
• when higher doses are given, mutant mice continue to have a higher survival rate than controls
|
immune system
• there is a significant reduction of the NK cell population expressing c-Kit in the bone marrow as well as in the spleen
• the reduction of c-Kit+ NK cells occurs in the transition from immature to mature NK cells rather than earlier
• NK cells expressing Ly49A are reduced in the spleen and bone marrow
• in addition, NK populations in the bone marrow expressing CD11bhi and CD43hi are reduced as well as NK cells expressing Klrg1
• immature NK cells in the bone marrow have a higher proliferation rate and also have a faster differentiation and transition from the stage III to the more mature stage V
|
• T and B cell numbers are reduced in the spleen but not in other organs (i.e. lymph nodes, thymus, etc.)
|
• T and B cell numbers are reduced in the spleen but not in other organs (i.e. lymph nodes, thymus, etc.)
|
• spleen cellularity is reduced by a third to a half due to smaller numbers of T and B cells
• reduced lymphocytes numbers are restricted to the spleen as lymph node numbers are normal
|
• immature NK cells in the bone marrow have a higher proliferation rate
• NK cells are more susceptible to apoptosis in culture, and less responsive to the anti-apoptotic effects of IL-2 and IL-15
• NK cells produce more IFN-gamma than controls in response to Chinese Hamster Ovary cells, anti-NK1.1 stimulation, and to MCMV infection
|
• NK cells are less able to kill tumor cell lines expressing an NG2GD ligand
• NK cells are able to kill cells lacking MHC-I expression at the same efficiency as wild-type NK cells
|
• NK cells have increased IFN-gamma secretion in response to Chinese Hamster Ovary cells, anti-NK1.1 stimulation, and to MCMV infection
|
• mice are resistant to MCMV infection
• when infected with a strain of MCMV that won't trigger Ly49H-mediated cytolysis, mice have a 10-fold lower viral titer 4 days after infection
• NK cells in infected mice show faster maturation and/or migration in the spleen compared to controls
|
• when infected with a LD50 dose of wild-type MCMV, about 90% of mice survive compared to 50-60% of wild-type
• when higher doses are given, mutant mice continue to have a higher survival rate than controls
|
hematopoietic system
• there is a significant reduction of the NK cell population expressing c-Kit in the bone marrow as well as in the spleen
• the reduction of c-Kit+ NK cells occurs in the transition from immature to mature NK cells rather than earlier
• NK cells expressing Ly49A are reduced in the spleen and bone marrow
• in addition, NK populations in the bone marrow expressing CD11bhi and CD43hi are reduced as well as NK cells expressing Klrg1
• immature NK cells in the bone marrow have a higher proliferation rate and also have a faster differentiation and transition from the stage III to the more mature stage V
|
• T and B cell numbers are reduced in the spleen but not in other organs (i.e. lymph nodes, thymus, etc.)
|
• T and B cell numbers are reduced in the spleen but not in other organs (i.e. lymph nodes, thymus, etc.)
|
• spleen cellularity is reduced by a third to a half due to smaller numbers of T and B cells
• reduced lymphocytes numbers are restricted to the spleen as lymph node numbers are normal
|
• immature NK cells in the bone marrow have a higher proliferation rate
• NK cells are more susceptible to apoptosis in culture, and less responsive to the anti-apoptotic effects of IL-2 and IL-15
• NK cells produce more IFN-gamma than controls in response to Chinese Hamster Ovary cells, anti-NK1.1 stimulation, and to MCMV infection
|
• NK cells are less able to kill tumor cell lines expressing an NG2GD ligand
• NK cells are able to kill cells lacking MHC-I expression at the same efficiency as wild-type NK cells
|